Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Authors:
- W.H. Wilson TangWTW.H. Wilson Tang
- Marie A. BakitasMBMarie A. Bakitas
- Xingxing S. ChengXCXingxing S. Cheng
- James C. FangJFJames C. Fang
- Savitri E. FedsonSFSavitri E. Fedson
- Amy G. FiedlerAFAmy G. Fiedler
- Pieter MartensPMPieter Martens
- Wendy I. McCallumWMWendy I. McCallum
- Modele O. OgunniyiMOModele O. Ogunniyi
- Janani RangaswamiJRJanani Rangaswami
- Nisha BansalNBNisha Bansal
- 15 October 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (16) , e280-e295
Abstract
Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In addition to elevations in serum creatinine, kidney dysfunction encompasses inadequate maintenance of sodium and volume homeostasis, retention of uremic solutes, and disrupted endocrine functions. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to fluctuations in kidney indices and electrolytes that may recover with guideline-directed medical therapy. Quantifying the extent of underlying irreversible intrinsic kidney disease is crucial in predicting whether optimization of congestion and guideline-directed medical therapy can stabilize kidney function. This scientific statement focuses on clinical management of patients experiencing kidney dysfunction through the trajectory of advanced heart failure, with specific focus on (1) the conceptual framework for appropriate evaluation of kidney dysfunction within the context of clinical trajectories in advanced heart failure, including in the consideration of advanced heart failure therapies; (2) preoperative, perioperative, and postoperative approaches to evaluation and management of kidney disease for advanced surgical therapies (durable left ventricular assist device/heart transplantation) and kidney replacement therapies; and (3) the key concepts in palliative care and decision-making processes unique to individuals with concomitant advanced heart failure and kidney disease.Keywords
This publication has 95 references indexed in Scilit:
- Fluctuations in Serum Creatinine Levels During Hospitalization and Long-Term End-Stage Kidney Disease and MortalityJAMA Network Open, 2023
- The Difference Between Cystatin C- and Creatinine-Based Assessment of Kidney Function in Acute Heart FailureESC Heart Failure, 2022
- The Trajectory of Renal Function Following Mechanical Circulatory Support and Subsequent Heart TransplantationESC Heart Failure, 2022
- Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2022
- Association of Gender and Race With Allocation of Advanced Heart Failure TherapiesJAMA Network Open, 2020
- Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2020
- Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2018
- Outcomes Associated With Left Ventricular Assist Devices Among Recipients With and Without End-stage Renal DiseaseJAMA Internal Medicine, 2018
- A Predictive Model for Progression of Chronic Kidney Disease to Kidney FailureJAMA, 2011
- Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE TrialArchives of internal medicine (1960), 2007